| ACCAs | Anti-chitobioside antibodies |
| AD | Alzheimer’s disease |
| AILD | Autoimmune liver disease |
| ALCAs | anti-laminaribioside antibodies |
| AMCA | anti-mannobioside IgG |
| AMPs | Antimicrobial peptides |
| APCs | Antigen-presenting cells |
| ASCAs | Anti-Saccharomyces cerevisiae antibodies |
| ASD | Autism spectrum disorder |
| ASF mice | Altered Schaedler flora mice |
| BD | Behçet’s disease |
| BD | Bipolar disorder |
| CD | Crohn’s disease |
| CRC | Colorectal cancer |
| DCs | Dendritic cells |
| DIA | Dot immunobinding assay |
| ELISA | Enzyme-linked immune sorbent assay |
| FMT | Fecal microbiota transplant |
| GC-B | Germinal center B |
| IBD | Inflammatory bowel disease |
| IECs | Intestinal epithelial cells |
| Igs | Immunoglobulins |
| IL | Interleukin |
| IMID | Immune-mediated inflammatory disease |
| MAC | Membrane attack complex |
| MALDI-TOF MS | Matrix Assisted Laser Desorption Ionisation—Time of Flight Mass Spectrometry |
| MHC | Major histocompatibility complex |
| MS | Multiple sclerosis |
| nAbs | Natural antibodies |
| NGS | Next-generation sequencing |
| PAMPs | Pathogen-associated molecular patterns |
| PBC | Primary biliary cirrhosis |
| PD | Parkinson’s disease |
| PMNs | Polymorphonuclear leukocytes |
| PRRs | Pattern recognition receptors |
| PSC | Primary sclerosing cholangitis |
| ROS | Reactive oxygen species |
| SCZ | Schizophrenia |
| SD | Seborrheic dermatitis |
| SHM | Somatic hypermutation |
| SWOT | Strengths, weaknesses, opportunities, and threats analysis |
| Tc cells | Cytotoxic T cells |
| TCRs | T cell receptors |
| Tfh cells | Follicular helper T cells |
| Th cells | Helper T cells |
| Treg cells | Regulatory T cells |
| UC | Ulcerative Colitis |
| WB | Western blotting |